| Variable | No. | % |
| 1) Age at Time of Diagnosis: |
|
|
| Range | 28 - 69 years. |
|
| Median | 48 years. |
|
| 2) Laterality: |
|
|
| RT Side | 26 | 48.1% |
| LT Side | 28 | 51.9% |
| 3) Quadrant Site |
|
|
| UO (Upper Outer) | 26 | 48.1% |
| UI (Upper Inner) | 7 | 13% |
| LO (Lower Outer) | 11 | 20.4% |
| LI (Lower Inner) | 6 | 11.1% |
| CE (Central) | 4 | 7.4% |
| 4) Tumor Grade |
|
|
| Grade 1 | 2 | 3.7% |
| Grade 2 | 43 | 79.6% |
| Grade 3 | 9 | 16.7% |
| 5) Tumor Histopathology |
|
|
| IDC (Infiltrating Ductal Carcinoma) | 52 | 96.3% |
| ILC (Infiltrating Lobular Carcinoma) | 2 | 3.7% |
| 6) T Stage: |
|
|
| T1 | 14 | 26% |
| T2 | 40
| 74% |
| 7) Node Stage: |
|
|
| N0 | 22 | 40.7% |
| N1 | 32 | 59.3 % |
| 8) Hormonal Receptors: |
|
|
| Positive ER and/or PR | 39 | 72.22% |
| Negative ER and/or PR | 15 | 27.78% |
| 9) Her 2 New Over-Expression: |
|
|
| No | 44 | 81.5% |
| Yes | 10 | 18.5% |